Your browser doesn't support javascript.
loading
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.
Citron, Marc L; Berry, Donald A; Cirrincione, Constance; Hudis, Clifford; Winer, Eric P; Gradishar, William J; Davidson, Nancy E; Martino, Silvana; Livingston, Robert; Ingle, James N; Perez, Edith A; Carpenter, John; Hurd, David; Holland, James F; Smith, Barbara L; Sartor, Carolyn I; Leung, Eleanor H; Abrams, Jeffrey; Schilsky, Richard L; Muss, Hyman B; Norton, Larry.
Affiliation
  • Citron ML; ProHEALTH Care Associates, LLP, 2800 Marcus Ave, Lake Success, NY 11042, USA. mcitron@prohealthcare.com
J Clin Oncol ; 21(8): 1431-9, 2003 Apr 15.
Article in En | MEDLINE | ID: mdl-12668651
Subject(s)
Search on Google
Print
XML
PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2003 Type: Article
Search on Google
Print
XML
PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2003 Type: Article